Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

Apheresis collection of PBMC in CD19 expressing malignancies who could be eligible for a CTL019

Protocol: OSU-14167

Full Title

A multicenter study of apheresis collection of peripheral blood mononuclear cells (PBMC) in patients with CD19 expressing malignancies who could be eligible for a CTL019 clinical research trial